BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19351850)

  • 1. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells.
    Ohashi E; Kogai T; Kagechika H; Brent GA
    Cancer Res; 2009 Apr; 69(8):3443-50. PubMed ID: 19351850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways.
    Kogai T; Ohashi E; Jacobs MS; Sajid-Crockett S; Fisher ML; Kanamoto Y; Brent GA
    J Clin Endocrinol Metab; 2008 May; 93(5):1884-92. PubMed ID: 18319322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells.
    Kogai T; Kanamoto Y; Li AI; Che LH; Ohashi E; Taki K; Chandraratna RA; Saito T; Brent GA
    Endocrinology; 2005 Jul; 146(7):3059-69. PubMed ID: 15817668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
    Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells.
    Dohán O; De la Vieja A; Carrasco N
    Mol Endocrinol; 2006 May; 20(5):1121-37. PubMed ID: 16439463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
    Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
    Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.
    Kogai T; Liu YY; Mody K; Shamsian DV; Brent GA
    J Biol Chem; 2012 Jan; 287(5):3292-300. PubMed ID: 22157753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intronic elements in the Na+/I- symporter gene (NIS) interact with retinoic acid receptors and mediate initiation of transcription.
    Alotaibi H; Yaman E; Salvatore D; Di Dato V; Telkoparan P; Di Lauro R; Tazebay UH
    Nucleic Acids Res; 2010 Jun; 38(10):3172-85. PubMed ID: 20123735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
    Unterholzner S; Willhauck MJ; Cengic N; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2006 Jan; 91(1):69-78. PubMed ID: 16234306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer.
    Knostman KA; McCubrey JA; Morrison CD; Zhang Z; Capen CC; Jhiang SM
    BMC Cancer; 2007 Jul; 7():137. PubMed ID: 17651485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
    Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
    J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models.
    Kogai T; Kanamoto Y; Che LH; Taki K; Moatamed F; Schultz JJ; Brent GA
    Cancer Res; 2004 Jan; 64(1):415-22. PubMed ID: 14729653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells.
    Tanosaki S; Ikezoe T; Heaney A; Said JW; Dan K; Akashi M; Koeffler HP
    Breast Cancer Res Treat; 2003 Jun; 79(3):335-45. PubMed ID: 12846418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
    Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
    J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
    Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
    Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.
    Dentice M; Luongo C; Elefante A; Romino R; Ambrosio R; Vitale M; Rossi G; Fenzi G; Salvatore D
    Mol Cell Biol; 2004 Sep; 24(18):7863-77. PubMed ID: 15340050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
    Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of iodide uptake and sodium/iodide symporter expression in the mcf-7 human breast cancer cell line.
    Arturi F; Ferretti E; Presta I; Mattei T; Scipioni A; Scarpelli D; Bruno R; Lacroix L; Tosi E; Gulino A; Russo D; Filetti S
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2321-6. PubMed ID: 15623812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
    Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.